Kronos Bio Announces Selection of Autoimmune Development Candidate for Sjögren’s Disease
October 07, 2024 08:55 ET
|
Kronos Bio, Inc.
– KB-7898, a p300 KAT inhibitor, is the Company's first development candidate for autoimmune diseases and originates from its proprietary discovery engine that decodes complex transcription factor...